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Results. We mention that homeopathy is a concept for the manufacture and use of various 
highly diluted products to treat diseases, which was created in 1796 by Samuel Hahnemann. 
His doctrine was based on ‘like cures like’, whereby a substance that causes a symptom is used 
to   treat the same symptom in illness. A second central principle is the ‘law of infinitesimals’, 
which involves a process of serial dilution and shaking that is asserted to increase potency. 
According to State Nomenclature of Medicines, the homeopathic pharmaceutical forms are 
presented in the top for tropane alkaloids: Belladonnae folia (Dentokind, Guna Dermo, 
Bronhalis Hell, Tonsilotren); followed by indole alkaloids: Strichni semina (Eubioflor, Guna 
Addict, Guna Bowel, Guna   Digest, Nux-Vomica, Mucosa compositum) and isoquinoline 
alkaloids: Berberidis folia (Discus Compositum, Reneel, Guna Diur) and Chelidonii herba 
(Hepeel, Hepar Compositum, Guna Addict). Pyrrolizidene, quinolizidine and acyclic alkaloids 
are presented with a smaller number of homeopathic products that those with indole alkaloids.   
Conclusions. Alkaloids have approximately 50 homeopathic pharmaceutical products after 
State Nomenclature of Medicines from Republic of Moldova, mostly in tablets, oral and 
injectable solutions.   
Key words: alkaloids, homeopathic medicinal products.   
 
429. ANTIOXIDANT NANOPARTICLES FOR PATHOLOGICAL 
ANGIOGENESIS INHIBITION: OBTAINING AND IN VIVO CAM MODEL 
EVALUATION 
Author: Adrian Duncă 
Scientific advisers: Oana-Maria Dragostin, PhD, Associate professor, Elena-Lăcrămioara Lisă, 
PhD, Associate professor, Dunarea de Jos University of Galati, Faculty of Medicine and 
Pharmacy 
 
Introduction. With an increasing incidence among young people, cancer is a disease that 
affects millions of people worldwide. Lately, many studies have been conducted to investigate 
the connection between antioxidants and pathological angiogenesis. In this context, the use of 
antioxidants in the form of nanoparticles could improve the efficiency of this therapy due to 
specific surface area of nanostructures, thereby ensuring a better contact with cells which 
would increase the chances of pathological angiogenesis inhibition.  
Aim of the study. In addition to the existing results, the purpose of the present work is to 
develop new nanoparticles based on chitosan low molecular weight derivatives for cancer 
therapy, taking into account not only their role as carriers but their action itself: the antioxidant 
potential which is benefical in inhibiting angiogenesis, as discussed above.  
Materials and methods. As a continuation of previous studies, carried out on chitosan, this 
paper purpose has as starting point the use of four previously obtained chitosan derivatives, 
note here with CLA, CLB, CLC and CLD, to obtain innovative nanoparticles formulations by 
ionic reticulation using as cross-linking agent sodium tri-polyphosphate (STPP). The infrared 
measurements were acquired with a Bruker ALPHA FT-IR spectrophotometer, in the spectral 
region of 4000-500 cm-1. For biological evaluation, in vivo CAM model was used, to assess 
the antiangiogenetic activity of chitosan derivatives nanoparticles.  
Results. In the spectrum of chitosan nanoparticles as well as that of its functionalized 
derivatives (CLA-CLD), the characteristic bands have been identified. In connection with 
biological evaluation, all four types of nanoparticles resulted in reduced angiogenesis, but the 
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maximum effect was observed in CLC and CLD cases, with significant decrease of vascular 
support.  
Conclusions. Our results demonstrate that chitosan derivatives nanoparticles strongly 
enhances the therapeutic effect of chitosan and the use of appropriate nanostructures, capable 
of overcoming biological barriers, could be an important strategy for future antitumor therapy.  
Funding: This work was supported by a grant of Ministry of Research and Innovation, CNCS 
- UEFISCDI, project number PN-III-P1-1.1-PD-2016- 0233, within PNCDI III. (Contract No. 
PD 144/2018).”  
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